| scholarly article | Q13442814 |
| P2093 | author name string | Shahar Rotem | |
| Amram Mor | |||
| Hadar Sarig | |||
| Dganit Danino | |||
| Lior Ziserman | |||
| P2860 | cites work | Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria | Q24550625 |
| Studies on anticancer activities of antimicrobial peptides | Q24650885 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| In vitro antibacterial properties of pexiganan, an analog of magainin | Q28343235 | ||
| Antifungal peptides: novel therapeutic compounds against emerging pathogens | Q28369443 | ||
| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies | Q29617810 | ||
| Intracellular targets of antibacterial peptides | Q30688421 | ||
| Tachyplesin activates the classic complement pathway to kill tumor cells | Q33216293 | ||
| Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides | Q33320587 | ||
| Structure-activity relationships of antibacterial acyl-lysine oligomers | Q33329010 | ||
| All-D amino acid-containing channel-forming antibiotic peptides | Q33643488 | ||
| In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action | Q33976229 | ||
| De novo design of biomimetic antimicrobial polymers | Q34023529 | ||
| Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii | Q34109543 | ||
| Antibacterial properties of dermaseptin S4 derivatives with in vivo activity | Q34113672 | ||
| Mode of action of membrane active antimicrobial peptides | Q35030295 | ||
| Ultrashort antibacterial and antifungal lipopeptides | Q35127593 | ||
| The potential of human neutrophil peptides in tuberculosis therapy | Q35576120 | ||
| Potential applications of microbial surfactants in biomedical sciences | Q35704540 | ||
| Defensin participation in innate and adaptive immunity | Q36990379 | ||
| Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids | Q37932475 | ||
| Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus | Q38898667 | ||
| Antiplasmodial activity of lauryl-lysine oligomers | Q40169806 | ||
| Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine | Q40267880 | ||
| The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro | Q40444626 | ||
| Therapeutic peptides revisited | Q40803178 | ||
| Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives | Q41826503 | ||
| Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides | Q42140552 | ||
| Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity | Q42158764 | ||
| Self-assembly of designed antimicrobial peptides in solution and micelles | Q42797906 | ||
| Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13). | Q43597969 | ||
| De novo design, synthesis, and characterization of antimicrobial beta-peptides | Q43692803 | ||
| Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. | Q43726823 | ||
| Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides | Q43767440 | ||
| Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis | Q43836533 | ||
| Antibacterial agents based on the cyclic D,L-alpha-peptide architecture | Q44022306 | ||
| Analysis of Membrane-Binding Properties of Dermaseptin Analogues: Relationships between Binding and Cytotoxicity | Q47407242 | ||
| Activity of dermaseptin K4-S4 against foodborne pathogens | Q47956641 | ||
| Pharmacokinetic investigation of a 14C-labelled beta 3/alpha tetrapeptide in rats | Q48326733 | ||
| Improved antimicrobial peptides based on acyl-lysine oligomers. | Q50995304 | ||
| In vitro discriminative antipseudomonal properties resulting from acyl substitution of N-terminal sequence of dermaseptin s4 derivatives. | Q51080439 | ||
| Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. | Q52545323 | ||
| Amphiphilic Poly(phenyleneethynylene)s Can Mimic Antimicrobial Peptide Membrane Disordering Effect by Membrane Insertion | Q60081234 | ||
| Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study | Q73106801 | ||
| Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity | Q73413971 | ||
| Multiple states of beta-sheet peptide protegrin in lipid bilayers | Q77710360 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | self-assembly | Q910150 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 4308-4314 | |
| P577 | publication date | 2008-10-06 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers | |
| P478 | volume | 52 |
| Q40205283 | A broad-spectrum bactericidal lipopeptide with anti-biofilm properties |
| Q33868731 | A miniature mimic of host defense peptides with systemic antibacterial efficacy |
| Q47848626 | Antibacterial activity and cytotoxycity of gelatine-conjugated lysine-based peptides |
| Q37274674 | Antibacterial properties and mode of action of a short acyl-lysyl oligomer |
| Q41209461 | Antifungal nanofibers made by controlled release of sea animal derived peptide |
| Q37877621 | Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. |
| Q40394438 | Biological and structural effects of the conjugation of an antimicrobial decapeptide with saturated, unsaturated, methoxylated and branched fatty acids |
| Q37778941 | Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold |
| Q38137920 | Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials |
| Q64121324 | Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides |
| Q40750300 | Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl |
| Q37392936 | In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori |
| Q42041041 | Mechanisms Mediating Bactericidal Properties and Conditions That Enhance the Potency of a Broad-Spectrum Oligo-Acyl-Lysyl |
| Q35781198 | Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides |
| Q38200572 | Nontraditional therapies to treat Helicobacter pylori infection |
| Q40387790 | Peptide fibrils as monomer storage of the covalent HIV-1 integrase inhibitor |
| Q50497238 | Potent Antimicrobial Activity of Lipidated Short α,γ-Hybrid Peptides. |
| Q38534935 | Role of peptide self-assembly in antimicrobial peptides |
| Q41420121 | Sensitization of Gram-negative bacteria to rifampin and OAK combinations |
| Q37875765 | Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action |
| Q41310768 | Synthesis and Surface Activity of Cationic Amino Acid-Based Surfactants in Aqueous Solution |
| Q34431490 | Synthesis and antibacterial activities of antibacterial peptides with a spiropyran fluorescence probe |
| Q31091020 | Synthesis, antibacterial activity and mode of action of novel linoleic acid-dipeptide-spermidine conjugates. |
| Q49490467 | The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs |
| Q35666413 | The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori |
| Q35173769 | Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? |
Search more.